Blue fog: Citalopram, methylene blue, serotonin syndrome

Toby N. Weingarten, Wayne T. Nicholson, Juraj Sprung

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This case discusses a pharmacodynamics interaction between citalopram and methylene blue, resulting in serotonin syndrome. Citalopram is a selective serotonin reuptake inhibitor and methylene blue is a reversible monoamine oxidase inhibitor.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Pages779-783
Number of pages5
ISBN (Print)9781461474951, 9781461474944
DOIs
StatePublished - Sep 15 2015

    Fingerprint

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Weingarten, T. N., Nicholson, W. T., & Sprung, J. (2015). Blue fog: Citalopram, methylene blue, serotonin syndrome. In A Case Approach to Perioperative Drug-Drug Interactions (pp. 779-783). Springer New York. https://doi.org/10.1007/978-1-4614-7495-1_175